TNBC is the most aggressive and chemoresistant subtype in breast cancer, with a typical characterization of lack of receptor expressions of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). Here, ESR1 is linked to breast cancer.